Buchumschlag

Other‐cause mortality in incidental prostate cancer

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Francesco Di Bello, Andrea Baudo, Mario de Angelis, Letizia Maria Ippolita Jannello, Carolin Siech, Zhe Tian, Jordan A. Goyal, Claudia Collà Ruvolo, Gianluigi Califano, Roberto La Rocca, Simone Morra, Pietro Acquati, Fred Saad, Shahrokh F. Shariat, Luca Carmignani, Ottavio de Cobelli, Alberto Briganti, Felix K. H. Chun, Nicola Longo, Pierre I. Karakiewicz
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2024
Schlagworte:	The Prostate
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Life Expectancy in High‐Grade Incidental Prostate Cancer Patients Versus Population‐Based Controls According to Treatment Type
von: Francesco Di Bello, et al.
Veröffentlicht: (2024)

USPSTF Recommendation Against PSA Screening vs. Stage and Cancer‐Specific Mortality in Localized Prostate Cancer
von: Fabian Falkenbach, et al.
Veröffentlicht: (2025)

Modern predictors and management of incidental prostate cancer at holmium enucleation of prostate
von: Eric V. Li, et al.
Veröffentlicht: (2024)

Effect of Marital Status on Years of Life Lost From Metastatic Prostate Cancer According to Race/Ethnicity
von: Leonardo Quarta, et al.
Veröffentlicht: (2026)

Survival of patients with lymph node versus bone versus visceral metastases according to CHAARTED/LATITUDE criteria in the era of intensified combination therapies for metastatic hormone‐sensitive prostate cancer
von: Mike Wenzel, et al.
Veröffentlicht: (2024)

Size and SUVmax define the contribution of nodal metastases to PSA in oligorecurrent prostate cancer
von: Fabian Falkenbach, et al.
Veröffentlicht: (2024)

Contemporary survival in metastatic bladder cancer patients: A population‐based study
von: Francesco Di Bello, et al.
Veröffentlicht: (2024)

Bellmunt risk score as a survival predictor in patients with metastatic castration‐resistant prostate cancer
von: Thomas Büttner, et al.
Veröffentlicht: (2024)

Does larger prostate size provide protection for cancer specific outcomes in localized prostate cancer
von: Zain Abedali, et al.
Veröffentlicht: (2024)

Cutibacterium acnes invades prostate epithelial cells to induce BRCAness as a possible pathogen of prostate cancer
von: Shingo Ashida, et al.
Veröffentlicht: (2024)

Diagnosis and management of neuroendocrine prostate cancer
von: Ivan de Kouchkovsky, et al.
Veröffentlicht: (2024)

Influence of microbiome in intraprostatic inflammation and prostate cancer
von: Pranav Prakash, et al.
Veröffentlicht: (2024)

Consistent predictive ability of prostate‐specific antigen density prediction model for clinically significant prostate cancer across age strata
von: Kamil Malshy, et al.
Veröffentlicht: (2024)

Analysis of three primary prostatic sarcoma cases and literature review
von: Yirui Wei, et al.
Veröffentlicht: (2024)

FOXA1 regulates ribosomal RNA transcription in prostate cancer
von: Tianwei Jia, et al.
Veröffentlicht: (2024)

Translation and validation of a lifestyle questionnaire related to prostate cancer
von: Reyhane Karegar‐Niavol, et al.
Veröffentlicht: (2024)

Key learnings from concordant systematic biopsies in prostate‐specific membrane antigen positron emission tomography/computed tomography‐guided prostate biopsies: Enhancing targeting accuracy
von: Thomas Büttner, et al.
Veröffentlicht: (2024)

The role of gut microbiota involved in prostate microenvironment and symptoms improvement in chronic prostatitis/chronic pelvic pain syndrome patients treated with low‐intensity extracorporeal shock wave
von: Xiangbin Kong, et al.
Veröffentlicht: (2024)

Investigation of pelvic floor influence on prostate displacement in image‐guided radiotherapy
von: Hongbo Chai, et al.
Veröffentlicht: (2024)

Three‐dimensional ultrastructural and anatomical analysis of prostatic neuroendocrine cells in mice
von: Kei‐Ichiro Uemura, et al.
Veröffentlicht: (2024)

Ejaculatory and erectile function outcomes following holmium laser enucleation of the prostate
von: Chinade Roper, et al.
Veröffentlicht: (2024)

Retrospective analysis of the learning curve in perineal robot‐assisted prostate biopsy
von: Ruth Himmelsbach, et al.
Veröffentlicht: (2024)

The detection rate for prostate cancer in systematic and targeted prostate biopsy in biopsy‐naive patients, according to the localization of the lesion at the mpMRI: A single‐center retrospective observational study
von: Matteo Massanova, et al.
Veröffentlicht: (2024)

Cumulative cancer locations on prostate biopsy and active surveillance outcomes in the MRI era
von: Sean A. Fletcher, et al.
Veröffentlicht: (2024)

Lower urinary tract symptoms in elderly men: Considerations for prostate cancer testing
von: Stephen Schmit, et al.
Veröffentlicht: (2024)

Performance of large language models on benign prostatic hyperplasia frequently asked questions
von: YuNing Zhang, et al.
Veröffentlicht: (2024)

L1CAM mediates neuroendocrine phenotype acquisition in prostate cancer cells
von: Chia‐Ling Hsieh, et al.
Veröffentlicht: (2024)

Testosterone bounce predicts favorable prognoses for prostate cancer patients treated with degarelix
von: Shuhei Kamada, et al.
Veröffentlicht: (2024)

Development and validation of an imageless machine‐learning algorithm for the initial screening of prostate cancer
von: Nicolas Martelin, et al.
Veröffentlicht: (2024)

Does Laterality Affect the Risk of Intraoperative Complications in Adrenalectomy?
von: Lukas Scheipner, et al.
Veröffentlicht: (2026)

Distribution of neurovascular structures within the prostate gland and their relationship to complications after radical prostatectomy
von: Ghazi Alanazi, et al.
Veröffentlicht: (2024)

Outcomes of 10 years of PSA screening for prostate cancer in Norwegian men with Lynch syndrome
von: Eli Marie Grindedal, et al.
Veröffentlicht: (2024)

Assessing state‐of‐the‐art online large language models for patient education regarding prostatitis
von: Pengfei Zhang, et al.
Veröffentlicht: (2024)

Serum levels of prostate specific antigen, free PSA, [−2]proPSA, fPSA/tPSA ratio, Prostate Health Index, and glycosylation patterns of free PSA in patients with benign prostatic hyperplasia pharmacotherapy
von: Michal Jirásko, et al.
Veröffentlicht: (2024)

Real‐world study: Impact of multidisciplinary management of apalutamide‐associated adverse events in prostate cancer
von: Julián Córdoba Sánchez, et al.
Veröffentlicht: (2024)

Comparison of abiraterone, enzalutamide, and apalutamide for metastatic hormone‐sensitive prostate cancer: A multicenter study
von: Takafumi Yanagisawa, et al.
Veröffentlicht: (2024)

PIK3/Akt/mTOR pathway alterations in metastatic castration‐sensitive prostate cancer
von: Philip Sutera, et al.
Veröffentlicht: (2024)

Machine learning and explainable artificial intelligence to predict pathologic stage in men with localized prostate cancer
von: Hemal Semwal, et al.
Veröffentlicht: (2024)

Minimally invasive surgical therapies for benign prostatic hyperplasia in the geriatric population: A systematic review
von: Ahmad Abid, et al.
Veröffentlicht: (2024)

An orthotopic prostate cancer model for new treatment development using syngeneic or patient‐derived tumors
von: Naz Chaudary, et al.
Veröffentlicht: (2024)